I-Herceptin Therapy for Cancer Breast

U-Herceptin, owaziwa nangokuthi igama lakhe elivamile elithi trastuzumab , imithi yokwelapha i- chemotherapy evunyelwe ukwelapha umdlavuza webele we- adjuvant nomdlavuza webele we- metastatic. Kuyisisekelo seprotheyini ehlose futhi sibophezele ku-protein HER2 (isifo se-epidermal factor receptor2). Abantu abangaba-1 kwabangu-4 abanomdlavuza wesifuba banomdlavuza wesifuba we-HER2 noma amaprotheni womuntu we-epidermal growth factor receptor2.

I-HER2 ngumdlavuza wesifuba othukuthelayo okhula ngokushesha futhi usakazeka ngokushesha.

Sibutsetelo

I-Adjuvant Cancer Breast ne-Herceptin

U-Herceptin uphatha umdlavuza webele wesandulela-ngculaza obizwa nge-HER2-positive futhi kungenzeka noma awusakazeki emakhanini lymph . Kumdlavuza webele we-adjuvant, i-Herceptin isetshenziselwa njengengxenye yenkambo yokwelapha ngesikhathi se-chemotherapy.

I-Metastatic Breast Cancer no-Herceptin

I-Herceptin ivunyelwe ukwelapha umdlavuza webele we-metastatic ngezindlela ezimbili. Ingasetshenziselwa ukuhlanganiswa nemithi ye-chemthrapie paclitaxel noma ingasetshenziswa yedwa iziguli ezitholile kakade i-chemotherapy ngenxa yomdlavuza webele we-metastatic.

Indlela Esebenza ngayo

I-Herceptin iyingxenye yekilasi lezidakamizwa okuthiwa yizokwelapha ze-biologic. Lesi sidakamizwa sisebenza ngokuzingela kuphela lawo maseli omdlavuza one-HER2 / neu receptors engaphandle kwawo. Igazi le-HER2 lenza i-protein receptor ebusweni beselula. Le receptor isayina iseli ukuhlukanisa nokuphindaphinda.

Uma kune-HER2 eningi kakhulu emathisini omdlavuza wesifuba, ukuhlukana kweseli akupheli, kukhula ngokushesha kakhulu. I-Herceptin ifinyelela kuma-receptor we-HER2 futhi ivimbela isignali yokukhula, ivimbele ukuhlukaniswa kwamaseli amaningi nokunciphisa ukuqhubeka komdlavuza.

Kuyinto emhlophe ephuzi noma ephuzi oketshezi ngokuvamile ephathwa ngokusebenzisa chemotherapy.

Ukuphatha

I-Herceptin ilawulwa nge- infotherapy. Umthamo wakho wokuqala uzonikezwa kancane esimisweni somzuzu-90 ukuze ubone ukuthi ubekezelela kangakanani izidakamizwa futhi ubukele ukusabela kokugula. Uma wenza kahle ngo-Herceptin, ukulandelana kwakho okulandelayo kunganikezwa ngemizuzu engama-30.

Okuqhamuka uma udla imishanguzo

Ezinye iziguli ezithola i-Herceptin ngomdlavuza wesifuba zalemiphumela emibi elandelayo:

Ezinye iziguli ezithola i-Herceptin ngenxa yomdlavuza we-metastatic esiswini zaba nemiphumela emibi elandelayo:

Lezi zimpawu ngokuvamile zivele zingakapheli amahora angu-24 ukuthola i-Herceptin.

Uma une-reactionergic reaction ku-Herceptin, shayela udokotela wakho ngokushesha. Izimpawu zokwelapha zihlanganisa ukuphefumula okuncane kakhulu, ukuqhuma, ukuvuvukala komphimbo noma izindebe kanye nemihlathi. Izimpawu eziphuthumayo zifaka ubuhlungu bokuphefumula nesifuba.

Izingozi

I-Herceptin ingabangela izinkinga zenhliziyo nokuhluleka kwenhliziyo ukugubha. Umsebenzi wakho we-ventricular wesokunxele udinga ukuhlolwa ngokushesha ngaphambi kokuba uqale u-Herceptin, ngezikhathi ezithile ezivamile ngenkathi ku-Herceptin (izincomo zokufaka iphakethe njalo ezinyangeni ezintathu), nangemva kokuqeda ukwelashwa kuka-Herceptin. Ingozi yezinkinga zenhliziyo iyanda uma uphathwa nge-Adriamycin no-Cytoxan kanye no-Herceptin.

Ungathathi Ithemba Uma:

Izincomo Ngesikhathi Ukwelashwa

Incologists iningi lincoma ukuthi ugweme ukusetshenziswa kotshwala, ugwayi, noma i-caffeine ngenkathi ukwelashwa no-Herceptin.

I-caffeine ibangela ukuma kwezingcuba zakho, okwenza kube nemiphumela yokomisa esivele ibangelwa izidakamizwa zakho ze-chemo. Tshela ithimba lakho lokwelapha uma usebenzisa ugwayi, izidakamizwa zokuphuza utshwala noma zokuzilibazisa, futhi ucele usizo lokuyeka ukusebenzisa lezi zidakamizwa. Sebenzisa ukukhulelwa ngokweqile ngenkathi ukwelashwa no-Herceptin, ngoba lesi sidakamizwa singabangela ukulimaza ingane uma ukhulelwe. Uma usuvele ukhulelwe, qiniseka ukuthi utshele udokotela wakho.

Amathiphu Wokuziqhenya

Umthombo

I-FDA. Ulwazi Lwezidakamizwa. Imininingwane ye-Label yomkhiqizo we-Trastuzumab. Kubuyekezwe: September 2013.